RELATIONSHIP BETWEEN STUDY WITHDRAWAL AND BASELINE CHARACTERISTICS IN ADOLESCENTS AND ADULTS WITH MODERATE TO SEVERE PERSISTENT ASTHMA.

被引：0
|
作者：
Rosenwasser, L. J.
Spector, S. L.
Uryniak, T.
Aggarwal, A.
Martin, U. J.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2011年 / 107卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：A36 / A36
页数：1
相关论文
共 50 条
  • [21] Dupilumab efficacy in severe asthma exacerbations by different baseline patient characteristics in patients with uncontrolled persistent asthma
    Fabbri, L. M.
    Bernstein, J. A.
    Staudinger, H.
    Maroni, J.
    Rowe, P.
    Jayawardena, S.
    Joish, V. N.
    Eckert, L.
    Amin, N.
    Akinlade, B.
    Pirozzi, G.
    Graham, N. M.
    Teper, A.
    ALLERGY, 2017, 72 : 108 - 109
  • [22] The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control
    Korn, Stephanie
    Milger, Katrin
    Skowasch, Dirk
    Timmermann, Hartmut
    Taube, Christian
    Idzko, Marco
    Voss, Hans Werner
    Holtdirk, Annette
    Hamelmann, Eckard
    Buhl, Roland
    RESPIRATORY MEDICINE, 2022, 195
  • [23] The relationship between vitamin D and moderate/severe persistent allergic rhinitis
    Xiong, P.
    Wu, H.
    Wang, F.
    Lu, Q.
    Liu, B.
    Peng, S.
    REVUE FRANCAISE D ALLERGOLOGIE, 2021, 61 (03): : 161 - 164
  • [24] Safety of budesonide (BUD) and formoterol (FM) in one pressurized metered-dose inhaler (BUD/FM pMDI) in adults and adolescents with mild to moderate persistent asthma.
    Korenblat, P. E.
    Corren, J.
    Miller, C. J.
    O'Brien, C. D.
    Mezzanotte, W. S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2007, 98 (01) : A57 - A57
  • [25] EFFECT OF OMALIZUMAB ON SEASONAL EXACERBATIONS IN ADOLESCENTS AND ADULTS WITH MODERATE-TO-SEVERE ALLERGIC ASTHMA
    Corren, J.
    Casale, T.
    Haselkorn, T.
    Yang, M.
    Iqbal, A.
    Ortiz, B.
    Busse, W.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S6 - S7
  • [26] SEVERE EXACERBATION RISK FOR US ADULTS AND ADOLESCENTS TREATED FOR INTERMITTENT VS PERSISTENT ASTHMA: RELATIONSHIP TO PRIOR EXACERBATIONS AND SYMPTOM CONTROL
    Lugogo, Njira L.
    Pollack, Michael
    Gilbert, Ileen
    Gandhi, Hitesh N.
    Tkacz, Joseph
    Lanz, Miguel J.
    CHEST, 2023, 164 (04) : 59A - 62A
  • [27] BASELINE CHARACTERISTICS OF PATIENTS WITH MODERATE-TO-SEVERE ASTHMA WITH AND WITHOUT COEXISTING ATOPIC DERMATITIS PARTICIPATING IN THE RAPID REGISTRY STUDY
    Peters, Anju T.
    Cote, Andreanne
    Munoz, Xavier
    Xia, Changming
    Nash, Scott
    Hardin, Megan
    Gomez, Lucia de Prado
    Sacks, Harry
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    Soler, Xavier
    CHEST, 2023, 164 (04) : 38A - 39A
  • [28] Cost-effectiveness analysis of omalizumab in adults and adolescents with moderate-to-severe allergic asthma
    Oba, Y
    Salzman, GA
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (02) : 265 - 269
  • [29] Budesonide (BUD) and formoterol (FM) in one pressurized metered-dose inhaler (BUD/FM pMDI): Effects on lung function and measures of asthma control in adults and adolescents with mild to moderate persistent asthma.
    Corren, J.
    Korenblat, P. E.
    Miller, C. J.
    O'Brien, C. D.
    Mezzanotte, W. S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2007, 98 (01) : A56 - A56
  • [30] COST-UTILITY ANALYSIS OF DUPILUMAB IN ADULTS AND ADOLESCENTS WITH UNCONTROLLED PERSISTENT SEVERE ASTHMA IN PORTUGAL
    Silva, C.
    Carreiro-Martins, P.
    Ferreira, J.
    Arrobas, A.
    Mendes, A.
    Faria, M.
    Rocha-Goncalves, F. N.
    VALUE IN HEALTH, 2022, 25 (12) : S166 - S167
12345